MARKET

CTLT

CTLT

Catalent
NYSE

Real-time Quotes | Nasdaq Last Sale

102.94
+2.46
+2.45%
Opening 15:52 05/14 EDT
OPEN
100.99
PREV CLOSE
100.48
HIGH
103.60
LOW
100.37
VOLUME
527.24K
TURNOVER
--
52 WEEK HIGH
127.68
52 WEEK LOW
67.97
MARKET CAP
17.53B
P/E (TTM)
34.79
1D
5D
1M
3M
1Y
5Y
Catalent Publishes Second Annual Corporate Responsibility Report Highlighting Achievements in an Extraordinary Year for the Pharmaceutical Industry
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene and therapies, and consumer health products, today published its Corporate Responsibili...
BusinessWire · 1d ago
Minerva (NERV) Soars on Promising Schizophrenia Study Data
Zacks.com · 2d ago
Sea Salt Nasal Spray Market Research Report - Covid-19 Impact on Industry Size 2021: Business Overview and Global Industry Challenges, Growth Drivers, Trends and Share Analysis Forecast to 2026
May 12, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." This “Sea Salt Nasal Spray Market” report...
The Express Wire · 2d ago
Biotherapeutics Market with Industry Growth Analysis 2021: Latest Trends and Challenges, Application Segment and Geographical Landscape Forecast to 2026 with global Impact of Covid-19
May 12, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry.” Global “Biotherapeutics Market” report...
The Express Wire · 2d ago
Contract Manufacturing Organization Market 2021 | Global Share, Growth, Scope, Challenges, Trends, Size, Suppliers, Export Research Report and Forecast to 2026
May 12, 2021 (The Expresswire) -- Contract Manufacturing Organization Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast...
The Express Wire · 2d ago
8-K: Catalent, Inc.
(EDGAR Online via COMTEX) -- false 0001596783 0001596783 2021-05-07 2021-05-07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 2d ago
Catalent Announces Chief Financial Officer Succession
Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today
Benzinga · 3d ago
Catalent promotes internal candidate to serve as SVP & CFO
Catalent (CTLT) promoted Thomas Castellano to SVP & CFO position, effective June 1, succeeding Wetteny Joseph who stepped down to join Zoetis (ZTS) as CFO.Currently, Mr. Castellano serves as the company's global
Seekingalpha · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CTLT. Analyze the recent business situations of Catalent through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 13 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CTLT stock price target is 134.70 with a high estimate of 142.00 and a low estimate of 120.00.
EPS
Institutional Holdings
Institutions: 640
Institutional Holdings: 183.06M
% Owned: 107.47%
Shares Outstanding: 170.34M
TypeInstitutionsShares
Increased
199
5.97M
New
97
9.74M
Decreased
168
9.69M
Sold Out
39
1.56M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.56%
Pharmaceuticals & Medical Research
+1.17%
Key Executives
Chairman/Chief Executive Officer/Director
John Chiminski
President/Chief Operating Officer
Alessandro Maselli
Chief Financial Officer/Senior Vice President
Wetteny Joseph
Corporate Executive
Jonathan Arnold
Corporate Executive
Karen Flynn
Corporate Executive
Manja Boerman
Corporate Executive
Aristippos Gennadios
Corporate Executive
Ricci Whitlow
Chief Human Resource Officer/Senior Vice President
Ricardo Pravda
Corporate Executive
Mario Gargiulo
Senior Vice President/Chief Information Officer
Charles Lickfold
Senior Vice President/General Counsel/Secretary
Steven Fasman
Senior Vice President
Michael Grippo
Senior Vice President
Scott Gunther
Senior Vice President
Kay Schmidt
Senior Vice President
Mike Grippo
Vice President
Z Mahdavi
Lead Director/Independent Director
Jack Stahl
Vice President - Operations
Jim Walter
Director
Michael Barber
Independent Director
Madhavan Balachandran
Independent Director
J. Martin Carroll
Independent Director
Rolf Classon
Independent Director
Rosemary Crane
Independent Director
John Greisch
Independent Director
Christa Kreuzburg
Independent Director
Gregory Lucier
Independent Director
Donald Morel
Independent Director
Peter Zippelius
No Data
About CTLT
Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels. The Drug Delivery Solutions segment is engaged in the formulation, development and manufacturing of prescription and consumer and animal health products; blow-fill seal unit dose manufacturing; biologic cell line development; analytical and bioanalytical development, and testing services. The Clinical Supply Services segment is engaged in manufacturing, packaging, labeling, storage, distribution and inventory management for clinical trials of drugs and biologics for patient kits; FastChain clinical supply service; clinical e-solutions and informatics, and global comparator sourcing services.

Webull offers kinds of Catalent Inc stock information, including NYSE:CTLT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTLT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CTLT stock methods without spending real money on the virtual paper trading platform.